Akr1c14

The regulation of AKR1C14 expression and activity is not well understood. It is possible that its expression and activity are regulated by factors such as hormones, genetic variations, or cellular signaling pathways, but further research is needed to determine the precise regulatory mechanisms.

As AKR1C14 is not well studied, there is limited information on its specific substrates. However, based on its membership in the AKR superfamily, it is likely to have a broad substrate specificity for aldehydes and ketones.

AKR1C14 is primarily expressed in the liver, but it might also be found in other tissues to some extent.

There is limited information available regarding the involvement of AKR1C14 in diseases. However, other members of the AKR superfamily have been implicated in various diseases, such as cancer and metabolic disorders. Further research is needed to elucidate the specific role of AKR1C14 in disease processes.

Currently, there is limited information available on genetic variations or mutations specifically associated with the AKR1C14 gene. Further studies are required to investigate if there are any functional genetic variations or mutations that may impact the protein's function or contribute to disease susceptibility.

AKR1C14 is expected to be located in the cytoplasm since most members of the AKR superfamily are cytosolic proteins. However, it is not known whether it may also be present in other cellular compartments, and further research is necessary to determine its precise subcellular localization.

The specific protein-protein interactions involving AKR1C14 are not well characterized. However, it is reasonable to expect that it could interact with other proteins in metabolic pathways or cellular processes where its activity is required.